News
Knowledge of respiratory syncytial virus (RSV) disease and RSV vaccine eligibility is low among hospitalized older adults, ...
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
Flu, RSV, and Covid-19 are still around and getting people sick. However, the number of cases has dropped recently in the ...
As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...
The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...
Actor Val Kilmer, 65, died of pneumonia this week, his daughter confirmed. Dr. Marc Siegel discusses common causes and risks ...
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
(NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology ...
GlaxoSmithKline (GSK) and Pfizer filed a stipulation to dismiss with prejudice GSK’s litigation in the United States District ...
Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...
GSK Plc and Pfizer Inc. settled a patent-infringement lawsuit over competing vaccines for RSV, ending the dispute in Delaware ...
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results